Probiotic Visbiome effects on Gut Microbiome and Immune Activation Markers
There’s a new, revolutionary research study on the way. It is investigating effects of the probiotic Visbiome Extra Strength on Gut Microbiome & Immune Activation Markers
This study is currently recruiting participants. Contact Information is available.
The ClinicalTrials.gov Identifier is NCT02706717
The study was verified in July 2016 by AIDS Clinical Trials Group
The study is sponsor by AIDS Clinical Trials Group
The collaborators are National Institute of Allergy and Infectious Diseases (NIAID) and Exegi Pharma, LLC
The estimated study completion date is December 2017.
Who is Eligible to Participate in the Visbiome Probiotic Research?
- Ages Eligible for Study: 18 Years and older (Adult, Senior)
- Genders Eligible for Study: Both
- Basic Inclusion Criteria:
HIV-1 infection, documented by any licensed rapid HIV test or HIV enzyme or chemiluminescence immunoassay (E/CIA) test kit at any time prior to study entry and confirmed by a licensed Western blot or a second antibody test by a method other than the initial rapid HIV and/or E/CIA, or by HIV-1 antigen, plasma HIV-1 RNA viral load.
Other criteria apply.
See ClinicalTrials.org for more information.
This information is provided by AIDS Clinical Trials Group
Purpose of the Visbiome Research Study
The purpose of the study is to evaluate whether the probiotic Visbiome Extra Strength reduces inflammation in HIV-infected men and women when compared to a placebo (inactive medication like a dummy pill).
This research study will evaluate whether taking Visbiome Extra Strength by mouth for 24 weeks is safe and well-tolerated for HIV-infected persons on antiretroviral therapy (ART).
Probiotics are germs such as yeast or bacteria that are found in food and supplements that are used to improve the health of the digestive system. Many people refer to probiotics as “helpful bacteria.” These bacteria live in the body and help the body work normally.
In some medical conditions, including HIV infection, helpful bacteria are replaced with bacteria that can change the normal intestinal function and increase inflammation.
The investigators will test whether giving Visbiome can restore normal intestinal function and decrease inflammation.